These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 36503459)

  • 21. Therapeutic bacteriophages as a rescue treatment for drug-resistant infections - an in vivo studies overview.
    Kwiatek M; Parasion S; Nakonieczna A
    J Appl Microbiol; 2020 Apr; 128(4):985-1002. PubMed ID: 31778593
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Paving the way for phage therapy using novel drug delivery approaches.
    Briot T; Kolenda C; Ferry T; Medina M; Laurent F; Leboucher G; Pirot F;
    J Control Release; 2022 Jul; 347():414-424. PubMed ID: 35569589
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bacteriophages Concept and Applications: A Review on Phage Therapy.
    Sahu R; Singh AK; Kumar A; Singh K; Kumar P
    Curr Pharm Biotechnol; 2023; 24(10):1245-1264. PubMed ID: 36336808
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The immunomodulatory potential of phage therapy to treat acne: a review on bacterial lysis and immunomodulation.
    Farfán J; Gonzalez JM; Vives M
    PeerJ; 2022; 10():e13553. PubMed ID: 35910763
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reassessment of Historical Clinical Trials Supports the Effectiveness of Phage Therapy.
    Marongiu L; Burkard M; Lauer UM; Hoelzle LE; Venturelli S
    Clin Microbiol Rev; 2022 Dec; 35(4):e0006222. PubMed ID: 36069758
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Searching for synergy: combining systemic daptomycin treatment with localised phage therapy for the treatment of experimental pneumonia due to MRSA.
    Valente LG; Federer L; Iten M; Grandgirard D; Leib SL; Jakob SM; Haenggi M; Cameron DR; Que YA; Prazak J
    BMC Res Notes; 2021 Sep; 14(1):381. PubMed ID: 34579784
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fitness Trade-Offs Resulting from Bacteriophage Resistance Potentiate Synergistic Antibacterial Strategies.
    Mangalea MR; Duerkop BA
    Infect Immun; 2020 Jun; 88(7):. PubMed ID: 32094257
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bacteriophages: an overview of the control strategies against multiple bacterial infections in different fields.
    Jamal M; Bukhari SMAUS; Andleeb S; Ali M; Raza S; Nawaz MA; Hussain T; Rahman SU; Shah SSA
    J Basic Microbiol; 2019 Feb; 59(2):123-133. PubMed ID: 30485461
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An Early History of Phage Therapy in the United States: Is it Time to Reconsider?
    Aswani VH; Shukla SK
    Clin Med Res; 2021 Jun; 19(2):82-89. PubMed ID: 34172535
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The resurgence of phage-based therapy in the era of increasing antibiotic resistance: From research progress to challenges and prospects.
    Anyaegbunam NJ; Anekpo CC; Anyaegbunam ZKG; Doowuese Y; Chinaka CB; Odo OJ; Sharndama HC; Okeke OP; Mba IE
    Microbiol Res; 2022 Nov; 264():127155. PubMed ID: 35969943
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stronger together? Perspectives on phage-antibiotic synergy in clinical applications of phage therapy.
    Segall AM; Roach DR; Strathdee SA
    Curr Opin Microbiol; 2019 Oct; 51():46-50. PubMed ID: 31226502
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Naturally-occurring and cultured bacteriophages in human therapy.
    Kiani AK; Anpilogov K; Dhuli K; Paolacci S; Benedetti S; Manara E; Guerri G; Dautaj A; Beccari T; Dundar M; Bertelli M
    Eur Rev Med Pharmacol Sci; 2021 Dec; 25(1 Suppl):101-107. PubMed ID: 34890040
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bacteriophage therapy: a potential solution for the antibiotic resistance crisis.
    Golkar Z; Bagasra O; Pace DG
    J Infect Dev Ctries; 2014 Feb; 8(2):129-36. PubMed ID: 24518621
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phages amid antimicrobial resistance.
    Mohan Raj JR; Karunasagar I
    Crit Rev Microbiol; 2019; 45(5-6):701-711. PubMed ID: 31775552
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Experimental Phage Therapies in Companion Animals with A Historical Review.
    Pyzik E; Radzki RP; Urban-Chmiel R
    Curr Rev Clin Exp Pharmacol; 2021; 16(1):17-29. PubMed ID: 32223736
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Past and Future of Phage Therapy and Phage-Derived Proteins in Patients with Bone and Joint Infection.
    Ferry T; Kolenda C; Briot T; Souche A; Lustig S; Josse J; Batailler C; Pirot F; Medina M; Leboucher G; Laurent F; On Behalf Of The Lyon Bji Study Group ; On Behalf Of The PHAGEinLYON Study Group
    Viruses; 2021 Dec; 13(12):. PubMed ID: 34960683
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of experimental phage therapies in livestock.
    Dec M; Wernicki A; Urban-Chmiel R
    Anim Health Res Rev; 2020 Jun; 21(1):69-83. PubMed ID: 32618543
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel antimicrobial agents for combating antibiotic-resistant bacteria.
    Chang RYK; Nang SC; Chan HK; Li J
    Adv Drug Deliv Rev; 2022 Aug; 187():114378. PubMed ID: 35671882
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bacteriophage Treatment Rescues Mice Infected with Multidrug-Resistant Klebsiella pneumoniae ST258.
    Hesse S; Malachowa N; Porter AR; Freedman B; Kobayashi SD; Gardner DJ; Scott DP; Adhya S; DeLeo FR
    mBio; 2021 Feb; 12(1):. PubMed ID: 33622728
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Bacteriophages in the battle against multidrug resistant bacteria].
    van der Meer JWM; Vandenbroucke-Grauls CMJE
    Ned Tijdschr Geneeskd; 2018; 162():D2433. PubMed ID: 29600928
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.